Post By Becca Trabin: Beware the Mental Health Adicle

The New York Times reports this week on the potential increase of what I like to call adicles. Adicles are what happens when journalists accept gifts or slanted information from pharmaceutical companies and then produce biased, pro-Pharma news articles. According to the NY Times:
Journalism awards consisting of cash prizes and all-expense-paid trips given out by drug companies are among the more “astonishing” financial ties between journalists and drug companies, the authors [of British Medical Journal] said.Among the prizes cited are the Embrace Award for reporting on urinary incontinence — consisting of trips to Washington, D.C., and Paris — offered by pharmaceutical firms Eli Lilly and Boehringer Ingelheim, as well as another Eli Lilly award for cancer treatment stories that includes a weeklong international trip for two.
The authors also point a finger at journalism training and education programs sponsored by the health care industry and to professorships funded by drug company grants. The writers go on to criticize reporters’ reliance on drug company press officers for referrals to experts or to patients, whose views may have been carefully screened.
In the mental health realm, you can spot potential adicles by the ease with which the author points to the use of pharmaceutical drugs as the solution to mental health problems, especially for children. Here’s an example of a Pharma/science/news hybrid entitled “Therapy plus Zoloft helps kids with anxiety”:
A popular antidepressant plus three months of psychotherapy dramatically helped children with anxiety disorders, the most common psychiatric illnesses in kids, the biggest study of its kind found.The research also offers comfort to parents worried about putting their child on powerful drugs — therapy alone did a lot of good, too.
Combining the drug sertraline, available as a generic and under the brand name Zoloft, with therapy worked best. But each method alone also had big benefits, said Dr. John Walkup [pictured], lead author of the government-funded research. It's estimated that anxiety disorders affect as many as 20 percent of U.S. children and teens.
Although the opening paragraphs state that the study was funded by the government (NIMH), it also says at the very bottom,
Several study authors reported receiving consulting fees or other compensation from drug companies, including antidepressant makers.
Furthermore, the seeming fairness of pointing out that therapy alone (actually, CBT) “did a lot of good, too” is countered by the fact that a mysterious estimate is included that one-fifth of all children have anxiety disorders. 20% of kids would benefit from some form of Zoloft!
If, on the one hand, doctors and researchers are in a diagnostic frenzy, the press in this instance is tacitly approving. On the other hand, if 20% of kids in the US really are impaired by serious anxiety, then it’s probably disadvantageous to society as whole for them to be taught from an early age that their anxieties are so internally created that they require chemical adjustments.
If corporations and medical professionals have a financial stake in selling soma (a la Huxley) to kids, it’s the responsibility of journalists to fully present the situation as such. Beware the adicles that tell you otherwise.







